Fredun Pharmaceuticals Ltd

AI
Fredun Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Fredun Pharmaceuticals Ltd

₹ 1,392 0.39%
29 Sep - close price
fredungroup.com BSE: 539730 NSE: FREDUN
About

Incorporated in 1987, Fredun Pharmaceuticals
Ltd manufactures & exports healthcare and pharmaceuticals products[1]

Key Points

Business Overview:{# https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ad9e590-baf1-43e5-a921-d0d5a2e4d356.pdf#page=2#}
The company is a diversified healthcare company engaged in pharmaceuticals, nutraceuticals, cosmeceuticals, dietary supplements, and animal healthcare products. Its pharmaceutical portfolio spans multiple therapeutic areas, including antihypertensives, antidiabetics, antiretrovirals (ARVs), and narcotics.

Website BSE NSE
  • Market Cap ₹ 2,303 Cr.
  • Current Price ₹ 1,392
  • High / Low ₹ 1,600 / 427
  • Stock P/E 52.6
  • Book Value ₹ 170
  • Dividend Yield 0.02 %
  • ROCE 21.3 %
  • ROE 15.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 97.8 to 53.2 days.

Cons

  • Stock is trading at 8.21 times its book value
  • Promoter holding has decreased over last 3 years: -4.74%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0 167 120 145 161 213 228
0 150 103 123 135 184 196
Operating Profit 0 17 17 22 26 29 33
OPM % 10% 14% 15% 16% 14% 14%
0 0 0 0 0 0 0
Interest 0 8 7 8 11 14 9
Depreciation 0 2 1 2 2 3 4
Profit before tax 0 7 9 13 14 11 21
Tax % 17% 25% 26% 25% 4% 36%
0 6 7 9 10 11 13
EPS in Rs 0.00 4.23 4.77 6.64 6.51 6.57 7.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026 TTM
454 635 748
401 545 637
Operating Profit 52 91 110
OPM % 12% 14% 15%
2 4 0
Interest 22 39 41
Depreciation 5 8 10
Profit before tax 27 47 59
Tax % 28% 31%
20 33 44
EPS in Rs 13.90 19.89 27.68
Dividend Payout % 2% 1%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 40%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 65%
Stock Price CAGR
10 Years: 67%
5 Years: 51%
3 Years: 65%
1 Year: 218%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 5 5
Reserves 137 273
167 222
179 142
Total Liabilities 487 642
53 118
CWIP 0 0
Investments 2 2
433 522
Total Assets 487 642

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
-17 12
-6 -74
27 121
Net Cash Flow 4 60
Free Cash Flow -23 -62
CFO/OP -32% 13%

Ratios

Consolidated / View Standalone

Mar 2025 Mar 2026
Debtor Days 142 53
Inventory Days 267 219
Days Payable 161 71
Cash Conversion Cycle 248 201
Working Capital Days 76 78
ROCE % 21%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Capsules Capacity
millions per day ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Granulation Capacity
kgs per day ・Standalone data
Tablet Compression Capacity
millions per day ・Standalone data
Countries with Product Registration / Export Presence
countries ・Standalone data
Cumulative Registered Products (Final Registrations)
products ・Standalone data
Products Under Registration (Pipeline)
products ・Standalone data
Contract / Third-Party Manufacturing Locations
locations ・Standalone data
Total SKUs (Stock Keeping Units)
SKUs ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Jul 2026
49.16% 49.17% 49.17% 48.93% 48.93% 48.93% 48.93% 48.93% 43.06% 44.17% 44.57% 44.57%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.46% 1.06% 1.06% 1.06%
1.60% 1.60% 1.60% 1.59% 1.59% 1.59% 1.59% 1.61% 3.48% 2.83% 2.94% 2.94%
49.24% 49.24% 49.23% 49.47% 49.47% 49.47% 49.49% 49.46% 53.00% 51.94% 51.45% 51.43%
No. of Shareholders 6,8377,5077,5118,0188,1217,9767,9068,1208,7658,3388,9039,598

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls